![]() | |
Names | |
---|---|
Preferred IUPAC name N-(Acetylcarbamoyl)-2-bromo-2-ethylbutanamide | |
Other names 1-Acetyl-3-(2-bromo-2-ethylbutyryl)urea | |
Identifiers | |
| |
3D model (JSmol) | |
ChEMBL | |
ChemSpider |
|
ECHA InfoCard | 100.000.953![]() |
EC Number |
|
KEGG |
|
MeSH | acecarbromal |
UNII | |
| |
| |
Properties | |
C9H15BrN2O3 | |
Molar mass | 279.134 g·mol−1 |
Pharmacology | |
Oral | |
Legal status |
|
Related compounds | |
Related compounds | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). |
Acecarbromal (INN) (brand namesSedamyl,Abasin,Carbased,Paxarel,Sedacetyl, numerous others), also known asacetylcarbromal andacetyladalin, is ahypnotic andsedativedrug of theureide (acylurea) group discovered byBayer in 1917[1] that was formerly marketed in theUnited States andEurope.[2][3] It is also used in combination with extract ofquebracho andvitamin E as a treatment forerectile dysfunction under the brand nameAfrodor in Europe.[4][5][6] Acecarbromal is structurally related to thebarbiturates, which are basically cyclizedureas.[7] Prolonged use is not recommended as it can causebromine poisoning.[7]